All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Ongoing | 2004-000876-14 | A multicentre, multinational, parallel, randomised, double blind clinical trial, to evaluate the non-inferiority of Prolonged Release Torasemide (PR) versus Immediate Release Torasemide (IR) in patien... | not-yet-due | |
| Reported results | 2005-004825-25 | CITICOLINE IN THE TREATMENT OF ACUTE ISCHEMIC STROKE. AN INTERNATIONAL RANDOMIZED MULTICENTER PLACEBO-CONTROLLED STUDY | 2012-05-22 | due-trials |
| Not reported | 2008-007055-28 | GF-001001-00 cream. A multicentre, randomised, double-blind, parallel, placebo-controlled phase II study to assess the efficacy and safety of 3 different doses of GF-001001-00 cream versus placebo cr... | 2010-03-26 | due-trials |
| Not reported | 2009-016655-21 | A Multi-Centre, Randomized, Placebo-controlled, Parallel-Group, Double-Blinded Study to Compare the Therapeutic Efficacy, Safety and Tolerability of 3 Single Vaginal Doses of Arasertaconazole Nitrate ... | 2010-11-15 | due-trials |
| Completed, but no date Terminated | 2010-019720-32 | Cardiovascular Fixed Combination Pill ASR: ensayo clínico farmacodinámico de la combinación a dosis fijas de ácido acetilsalicílico, simvastatina, y ramipril (Cardiovascular Polypill); Colesterol LDL ... | bad-data | |
| Ongoing | 2011-000972-32 | Estudio randomizado, abierto, con endpoint enmascarado, cruzado, de dosis única para comparar la farmacodinamia de TORASEMIDA- LP 10 mg, TORASEMIDA-LI 10 mg y FUROSEMIDA-LI 40 mg en pacientes con insu... | not-yet-due | |
| Not reported | 2011-003032-31 | A phase III 3 arms, multicenter, randomised, investigator-blind study to assess the efficacy and safety of ozenoxacin 1% cream applied twice daily for 5 days versus placebo in the treatment of patient... | 2012-12-28 | due-trials |
| Trial is outside EEC | 2012-000746-36 | A phase I open-label multiple dose study to examine the systemic bioavailability and safety of twice daily topical applications of ozenoxacin 1% cream formulation in patients with impetigo | bad-data | |
| Listed as ongoing, but also has a completion date | 2014-000228-52 | A phase III 2 arms, multicenter, randomised, double-blind study to assess the efficacy and safety of ozenoxacin 1% cream applied twice daily for 5 days versus placebo in the treatment of patients with... | 2015-05-30 | bad-data |
| Reported results | 2014-000456-29 | EFFICACY AND SAFETY OF INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC IN ACUTELY AGITATED PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER | 2016-10-31 | due-trials |
| Not reported | 2014-001966-87 | Double-blind, randomized, placebo-controlled cross-over dose finding study of two doses of lorediplon in adult patients with insomnia disorder Dvostruko slijepo, randomizirano, placebom kontroliran... | 2016-08-23 | due-trials |
| Reported results | 2015-003331-36 | A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of self-administered ADASUVE(R) (Staccato loxapine for inhalation) in Agitated Patients outside the hospital setting | 2019-12-31 | due-trials |
| Exempt | 2015-005717-80 | Clinical trial of phase 1/2 to evaluate the feasibility, safety, tolerability and preliminary efficacy of the administration of FAB117-HC, a drug whose active ingredient is HC016, allogeneic adipose d... | not-yet-due | |
| Reported results | 2016-004015-13 | A phase III, international, multicenter, randomized and open label study to evaluate the efficacy on LDLc and blood pressure reduction and safety of Trinomia® versus usual care in patients with very h... | 2019-12-11 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2017-002343-14 | A multicentre, randomised, open-label, parallel-group trial to study the safety and efficacy of a new therapeutic strategy (Trinomia®) versus usual care on LDLc and blood pressure levels in patients w... | 2021-03-09 | bad-data |
| Completed, but no date, and reported results | 2020-002753-22 | Safety and Efficacy of Favipiravir in COVID-19 Patients with Pneumonia −A randomized, double blind, placebo- controlled study − Seguridad y eficacia de Favipiravir en pacientes COVID-19 con neumoní... | bad-data | |
| Listed as ongoing, but also has a completion date | 2020-003376-40 | A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of FAB122 in patients with Amyotrophic Lateral Sclerosis | 2023-10-26 | bad-data |
| Listed as ongoing, but also has a completion date | 2022-003050-32 | A multicenter, open-label extension study to investigate the long-term safety of FAB122 in patients with Amyotrophic Lateral Sclerosis | 2024-02-22 | bad-data |